1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024

  • August 2015
  • -
  • GlobalData
  • -
  • 48 pages

Summary

Table of Contents

Search Inside

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024

Summary

Growth hormone deficiency (GHD) is an endocrine disorder characterized by low or deficient secretion of growth hormone (GH) secondary to malfunction of the pituitary gland, a pea-sized structure located at the base of the brain that is responsible for the production of GH. The International Classification of Diseases (ICD-10) ICD-10-CM code for GHD is E23.0.

GHD in children can be classified as idiopathic or organic, which is further divided into congenital and acquired. GH is necessary for normal growth, as it fuels childhood growth and development. In an adult’s normal lifespan, GH is needed to maintain the amounts of body fat, muscle, and bone necessary for sustaining tissue and organ function. GHD acquired in adulthood is usually acquired through damage to the pituitary-hypothalamic region through trauma or tumors. This report does not cover childhood-onset GHD that progresses into adulthood.

In the 7MM, the diagnosed prevalent cases of GHD for all ages and both sexes will increase from 97,985 cases in 2014 to 100,494 cases in 2024, at an Annual Growth Rate (AGR) of 0.26%. GlobalData epidemiologists forecast a small increase in the AGR of the diagnosed prevalent cases of GHD from 2014-2024 for all included markets except for Germany and Japan. The majority of diagnosed prevalent cases of GHD in children in the 7MM are in boys. In the 7MM, 68.05% of the GHD cases in children are in boys and the trend is consistent in the individual markets. In adults, the distribution is also skewed towards men in the US and the 5EU.

GlobalData epidemiologists maintained consistent forecast methodology across all the 7MM, thus allowing for a meaningful comparison of the included parameters across the 7MM.

Scope

- The Growth Hormone Deficiency (GHD) EpiCast Report provides an overview of the risk factors and global trends of GHD in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the GHD diagnosed in children (=18 years) and in adults (>18 years) segmented by sex from 2014-2024. The forecast also provides GHD diagnosed cases in children segmented by the etiological classifications (idiopathic and organic; organic further segmented into congenital and acquired). The forecast for GHD diagnosed in adults are further segmented by etiological classifications (idiopathic and acquired).
- The GHD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global GHD market.
- Quantify patient populations in the global GHD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for GHD therapeutics in each of the markets covered.
- Identify the percentage of GHD diagnosed prevalent cases by etiological classification.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.